Who
Holger Weis
CEO
Company insider
Files Form 4 as: CEO, Alaunos Therapeutics; Director, Jupiter Neurosciences.
In numbers
- Trades disclosed
- 31
- Buys
- 1
- Sells
- 0
- Bought
- $92K
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 4 Mar 2021
- Last trade
- 6 Oct 2026
- Last filed
- 8 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 6 Oct 2026filed 8 Oct 2026 | TCRT Alaunos TherapeuticsBiotechnology | SEC FORM 4 Code A | $18K23,564 at $0.7444 | filing |
| 6 Aug 2026filed 11 Aug 2026 | TCRT Alaunos TherapeuticsBiotechnology | SEC FORM 4 Code A | $8,7704,363 at $2.01 | filing |
| 6 Aug 2026filed 11 Aug 2026 | TCRT Alaunos TherapeuticsBiotechnology | SEC FORM 4 Code A | $8,7704,363 at $2.01 | filing |
| 23 Jul 2026filed 27 Jul 2026 | TCRT Alaunos TherapeuticsBiotechnology | SEC FORM 4 Code A | $8,7714,568 at $1.92 | filing |
| 23 Jul 2026filed 27 Jul 2026 | TCRT Alaunos TherapeuticsBiotechnology | SEC FORM 4 Code A | $8,7714,568 at $1.92 | filing |
| 30 Jun 2026filed 2 Jul 2026 | TCRT Alaunos TherapeuticsBiotechnology | SEC FORM 4 Code A | $8,7693,880 at $2.26 | filing |
| 30 Jun 2026filed 2 Jul 2026 | TCRT Alaunos TherapeuticsBiotechnology | SEC FORM 4 Code A | $8,7693,880 at $2.26 | filing |
| 12 Jun 2026filed 17 Jun 2026 | TCRT Alaunos TherapeuticsBiotechnology | SEC FORM 4 Code A | $18K7,761 at $2.26 | filing |
| 12 Jun 2026filed 17 Jun 2026 | TCRT Alaunos TherapeuticsBiotechnology | SEC FORM 4 Code A | $18K7,761 at $2.26 | filing |
| 2 Jun 2026filed 4 Jun 2026 | JUNS Jupiter Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 2 Jun 2026filed 4 Jun 2026 | JUNS Jupiter Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 22 May 2026filed 27 May 2026 | TCRT Alaunos TherapeuticsBiotechnology | SEC FORM 4 Code A | $8,7693,700 at $2.37 | filing |
| 22 May 2026filed 27 May 2026 | TCRT Alaunos TherapeuticsBiotechnology | SEC FORM 4 Code A | $8,7693,700 at $2.37 | filing |
| 18 Aug 2025filed 20 Aug 2025 | TCRT Alaunos Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —13,676 at $0.00 | filing |
| 2 Jul 2025filed 7 Jul 2025 | TCRT Alaunos Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —130,000 at $0.00 | filing |
| 2 Jun 2025filed 13 Jul 2026 | JUNS Jupiter NeurosciencesBiotechnology | SEC FORM 4 Code M | —85,800 | filing |
| 2 Jun 2025filed 13 Jul 2026 | JUNS Jupiter Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —85,800 at $0.00 | filing |
| 2 Jun 2025filed 13 Jul 2026 | JUNS Jupiter Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —85,800 at $0.00 | filing |
| 2 Jun 2025filed 13 Jul 2026 | JUNS Jupiter NeurosciencesBiotechnology | SEC FORM 4 Code M | —85,800 | filing |
| 13 Apr 2025filed 15 Apr 2025 | TCRT Alaunos Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,904 at $0.00 | filing |
News
Biotech Stock Alaunos Therapeutics (NASDAQ: TCRT) Sees Triple Digit Gains on Acquisition and FundingTCRT · investorideas.com · 13 Oct 2026Alaunos Therapeutics Announces Acquisition of Velaris TherapeuticsTCRT · manilatimes.net · 13 Oct 2026
0 headlines in the last 90 days name Holger Weis; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.